IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial
Journal article published in 2023 by
Quincy S. Chu,
Maria Carmela Piccirillo,
Laurent Greillier,
Federica Grosso,
Giuseppe Lo Russo,
Marie Florescu,
Manlio Mencoboni,
Penelope Ann Bradbury,
Alessandro Morabito,
Fabiana Letizia Cecere,
Sara Delfanti,
Arnaud Scherpereel,
Myriam Locatelli-Sanchez,
Gerard Zalcman 
,
David E. Dawe
and other authors.
,
David E. Dawe
and other authors.
